Company / Capital Returned to Shareholders per Share
Bruker Capital Returned to Shareholders per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Returned to Shareholders per Share
$0.22
FY2025
5-year range
$0.21 / $1.94
FY2021-FY2025
Trend
+3.9%
vs FY2024
Sector context
#82 of 103
Health Care
What the data says
Bruker's capital returned to shareholders per share of $0.22 is lower than 80% of companies in the Health Care sector (FY2025). Capital Returned to Shareholders per Share returned to growth in FY2025 after 2 years of decline, reaching $0.22.
Based on SEC 10-K filings.
0.22 in FY2025 with a 5-year CAGR of -25.8%.
Declined from $1.24 to $0.22 over the past 2 years.
Health Care sector context is included.
Capital Returned to Shareholders per Share over time
Growth rates
- 3-Year CAGR
- -51.9%
- 5-Year CAGR
- -25.8%
- 10-Year CAGR
- -
Sector benchmark
Bottom 20% in Health CareTop 80% of 103This company $0.22 Sector average $5.12
▼
-95.8% below sector average
Key checks
Key Insights
- In FY2025, capital returned to shareholders per share increased 3.9% year-over-year.
- Ranks #82 out of 103 companies in the Health Care sector.
- Peak capital returned to shareholders per share was recorded in FY2022.
- Lowest capital returned to shareholders per share in the period was in FY2018.
Annual data
| Year | Capital Returned to Shareholders per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.22 | +3.9% |
| FY2024 | $0.21 | -83.2% |
| FY2023 | $1.24 | -36.4% |
| FY2022 | $1.94 | +66.4% |
| FY2021 | $1.17 | +21.8% |
| FY2020 | $0.96 | -10.2% |
| FY2019 | $1.07 | +2543.0% |
| FY2018 | $0.04 | -95.9% |
| FY2017 | $0.99 | -11.7% |
| FY2016 | $1.12 | +110.4% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026